Loading clinical trials...
Loading clinical trials...
PTQA: A New Paradigm of Transfusion Decision Support for Patients With MDS
Conditions
Interventions
Peri-Transfusion QOL Assessment
Locations
1
United States
Dana Farber Cancer Institute
Boston, Massachusetts, United States
Start Date
October 17, 2018
Primary Completion Date
June 30, 2021
Completion Date
June 30, 2021
Last Updated
June 21, 2024
NCT07270978
NCT05292664
NCT06499285
NCT04953897
NCT04953910
NCT05350748
Lead Sponsor
Dana-Farber Cancer Institute
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions